Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03486028 · ClinicalTrials.gov registry record
Patient Centered Assessment and Substance Use Disorder Treatment Study (PCAST)
A clinical trial, sponsored by RTI International.
- Completed
- Registry status
- 991
- Enrollment target
NCT03486028 is a clinical trial that has completed, run by RTI International. The registered enrollment target is 991 participants.
The verdict
NCT03486028 has completed, sponsored by RTI International.
- COMPLETED
- Registry status
- 991 participants
- Enrollment target
Study Summary
California counties are in the process of implementing a Centers for Medicare and Medicaid Services Medicaid 1115 Substance Use Disorder (SUD) demonstration. The demonstration requires that patients be assigned to addiction treatment settings and levels of care systematically, using comprehensive biopsychosocial assessments and guided by the American Society of Addiction Medicine (ASAM) patient placement criteria. RTI International, a nonprofit research institute, and University of California Los Angeles (UCLA) Integrated Substance Abuse Programs have been awarded a contract from the Patient Centered Outcomes Research Institute (PCORI) to study the effects of the ASAM implementation in California. The California 1115 SUD demonstration provides a unique opportunity to learn about the benefits and challenges resulting from system-wide implementation of ASAM criteria. The study will involve surveying patients in counties that are using the ASAM criteria and in counties that have not yet adopted the ASAM criteria. Medicaid patients receiving addiction treatment will be offered the opportunity participate in the study and to be surveyed about their experiences in treatment. The study will also analyze data from the California Outcomes Management System (CalOMS) and conduct interviews with providers, patients, and policymakers in the state. The results of the study will help inform California's efforts to continually improve its addiction treatment systems to better meet the needs of it communities. This study will also produce important and useful information to patients seeking treatment for addiction, and their providers, SUD system administrators, and payers.
Interventions
- OTHER Adherence to ASAM protocols
- OTHER Non-adherence to ASAM protocols
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 991 participants |
| Start Date | 2018-07-31 |
| Est. Completion | 2019-10-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03486028
The ClinicalTrials.gov registry entry for NCT03486028 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 991 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RTI International, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Adherence to ASAM protocols is the first listed.
NCT03486028 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03486028 about?
NCT03486028 is a clinical study titled "Patient Centered Assessment and Substance Use Disorder Treatment Study (PCAST)". California counties are in the process of implementing a Centers for Medicare and Medicaid Services Medicaid 1115 Substance Use Disorder (SUD) demonstration. The demonstration requires that patients be assigned to addiction treatment settings and levels of care systematically, using comprehensive bi...
What is the current status of trial NCT03486028?
This trial is currently completed. The enrollment target is 991 participants. The study started on 2018-07-31. Estimated completion is 2019-10-27.
What interventions are being tested in trial NCT03486028?
The interventions under investigation include: Adherence to ASAM protocols (OTHER), Non-adherence to ASAM protocols (OTHER).
Who is sponsoring clinical trial NCT03486028?
This trial is sponsored by RTI International, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.